Biotechnology Latest Reports

15 years+ Industry research experience. Only Company which focuses on small product segmentation reports.

Global next generation sequencing market size is projected to be worth USD 36 Billion by 2026, expanding at CAGR of 18.2% during the forecast period (2022 - 2030), The market was valued at USD 6.47 Billion in 2021.

The term next generation sequencing (NGS) is an extremely parallel sequencing technology that provides ultra-high throughput, speed, and scalability. It is also identified as "high-throughput sequencing," referring to a range of modern sequencing technologies. This technology is utilized to determine the order of nucleotides in complete genomes or targeted regions of DNA or RNA, and also this technology makes it potential to sequence RNA and DNA in a dependable and cost-effective way. The requirements for next-generation sequencing are increasing overall in medical appliances as they are generally used in functional genomics to test DNA and RNA samples.

Next Generation Sequencing (NGS) Market: Growth Factors

Due to the continuous technological advancements in sequencers, the initiation of convenient, portable, and efficient NGS platforms are allowed that is capable of giving quick and exact outcomes and showing a better turnaround time where major players are mostly focused on the research & development of these products to make stronger their growth positions and revenues. This is driving the NGS market growth worldwide.  Also, the enhancement in genome mapping activities is boosting the global next-generation sequencing market in the near future.  Moreover, the major factors such as declining costs of genome sequencing and rising occurrence of cancer, the expansion in NGS platforms, and the growing usage of next-generation sequencing in cancer research centers are fuelling the market growth in the NGS across the globe.

Importantly, government associations are sequencing millions of genomes for the advancement of research as well as diagnosing and treating cancer disease and other diseases where large sequencing initiatives are likely to offer positive growth opportunities for key companies during the forecast period.

On the other hand, several academic & research institutes are facing budget limitations while purchasing and using advanced and premium-priced equipment and technologies, as academic research & development in emergent countries is usually dependent on external funding. Due to this, the development of advanced research amenities is hindered in the academic and research institutes in emergent countries. This, in turn, is impeding the market globally during the forecast period.

Next Generation Sequencing (NGS) Market: Regional Analysis

North America is leading the global next-generation sequencing market, followed by the European region, due to factors such as the growth in the utilization of next-generation sequencing in genomics research and diagnostics. Also, the launching of the latest products is propelling the market growth in the region.

Furthermore, the Asia-Pacific region is anticipated to have the largest market share in the forthcoming years as a result of the bigger investment by pharma and biotech industries is estimated to increase the user’s demand.

Next Generation Sequencing (NGS) Market: Top Market Players

Various players operating in the next-generation sequencing market cover Genomatix GmbH, Agilent Technology, PierianDx; DNASTAR Inc., Illumina, Eurofins GATC Biotech GmbH, QIAGEN, F. Hoffman-La Roche Ltd., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Bio-Rad Laboratories Inc., BGI Group, and Perkin Elmer Inc.

For example, PierianDx has strengthened its clinical and laboratory facility to effectively diagnose and cure cancer and other chronic diseases. In 2019, the company had raised a $26,870,702 series B round from ATW Partners, RTI International, and SJF Ventures.

Report Attribute Details
The market size value in 2021 USD 36 billion
The revenue forecast in 2030 USD 563 billion
Growth Rate CAGR of 18.2% from 2022 to 2030
The base year for estimation 2021
Historical data 2018 – 2020
Forecast period 2022 – 2030
Top Manufacturers Genomatix GmbH, Agilent Technology, PierianDx; DNASTAR Inc., Illumina, Eurofins GATC Biotech GmbH, QIAGEN, F. Hoffman-La Roche Ltd., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Bio-Rad Laboratories Inc., BGI Group, and Perkin Elmer Inc.
By Application Oncology, Clinical Investigation, Reproductive Health, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring
By Technology Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing, Others
By End-User
Academic Research, Clinical Research,  Hospitals & Clinics, Pharma & Biotech Entities, Other users
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa

This report segments the global next generation sequencing market as follows:

Global Next Generation Sequencing (NGS) Market: By Application

  • Oncology
  • Clinical Investigation
  • Reproductive Health
  • Metagenomics
  • Epidemiology & Drug Development
  • Consumer Genomics
  • Agrigenomics & Forensics
  • HLA Typing/Immune System Monitoring

Global Next Generation Sequencing (NGS) Market: By Technology

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing
  • Others

Global Next Generation Sequencing (NGS) Market: By End-User

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other users

Global Next Generation Sequencing (NGS) Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Global contract research organization (CRO) market was valued at around USD 43.7 Billion in year 2021 and is anticipated to generate revenue of almost USD 58.3 Billion by the end of year 2030. The global industry is growing at a healthy CAGR of approximately 9% during the 2021-2026. The latest report by Vertex Market Research on the global Contract Research Organization (CRO) Market offers insights and analysis regarding the various aspects and dynamics throughout the study period while providing their impacts on the overall market’s growth.

The contract research organizations (CRO) offer help to the biotechnology, pharmaceutical, and medical device companies. Factors such as the rising patient population, increasing demand for effective drugs and healthcare devices, and high expenditure of product expansion are responsible for the contract research organization market growth across the globe. Furthermore, augmented outsourcing services of research, the evolving research and development costs, and development programs, and expansion number of clinical trials are expected to fuel the growth of the market during the forecast period. The patent expiries leading to the general competition and severe demands from regulators will have a constructive impact on the bottom lines of pharmaceutical industries which is also contributing to the market.


Report Attribute Details
The market size value in 2021 USD 43.7 billion
The revenue forecast in 2030 USD 58.3 billion
Growth Rate CAGR of 9% from 2020 to 2028
The base year for estimation 2021
Historical data 2017 – 2019
Forecast period 2021 – 2026
Top Manufacturers IQVIA, Medpace, MPI Research, LabCorp, PAREXEL, PRA Health Sciences, Envi, ICON Plc, PPD Inc., Syneos Health, Charles River, WuXi PharmaTech, and SGS
By Type Early Phase Development Services , Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing, Clinic Research Services, Physical Characterization, Stability Testing, Batch Release Testing, Consulting Services, Others
By Application
Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies, Academic Institutes
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa


Growth Factors


Moreover, the heavy investment in research and development programs with a pipeline of therapeutics undergrowth will boost the market revenue of contract research organizations in the forthcoming years. The escalating number of services provided by contract research organizations and the intensifying tendency of collaborations are propelling the growth of the market. On the other hand, the COVID-19 pandemic has drastically impacted the contract research organizations market. The focus on finding a vaccine against coronavirus has a large impact on the expansion of other vaccines and drugs across the world.

Regional Analysis


Geographically, the contract research organization market has been classified into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is leading the contract research organization market in terms of revenue and will continue to expand over the forecast period which is followed by the Asia Pacific and Europe due to quick expansion in its biosimilars and biologics market, the high-quality standards in the pharmaceutical production companies, and rising activities in a clinical trial.

Moreover, the Asia-Pacific region is likely to grow in the future due to numerous factors such as the availability of trained laborers, beneficial government initiatives, the occurrence of a diverse population for proper clinical trials, and an increasing patient pool of chronic and infectious diseases. The Middle East and Africa are anticipated to increase in the forthcoming years as a result of increasing awareness regarding the treatment benefits, low-cost, expanding clinical trials activities, and the increasing load of several chronic diseases.

Top Market Players


Major market companies leading in the global contract research organization (CRO) market cover IQVIA, Medpace, MPI Research, LabCorp, PAREXEL, PRA Health Sciences, Envi, ICON Plc, PPD Inc., Syneos Health, Charles River, WuXi PharmaTech, and SGS.


This report segments the global contract research organization (CRO) market as follows:

Global Contract Research Organization (CRO): By Type

  • Early Phase Development Services
  • Pharmacokinetics/Pharmacodynamics (PK/PD)
  • Toxicology Testing
  • Clinic Research Services
  • Physical Characterization
  • Stability Testing
  • Batch Release Testing
  • Consulting Services
  • Others

Global Contract Research Organization (CRO): By Application

  • Pharmaceutical and Biopharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes


Global Contract Research Organization (CRO): Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Global cell culture media market is expected to be worth USD 1,524 Million by 2030, increasing at an 8.5% CAGR during the forecast period (2022 - 2030). The market was valued at USD 876.3 Million in 2021.

In microbiological laboratories and research centers, the culture media is used for growing and controlling cells. The cell culture media is constituted of a group of vitamins, inorganic salts, amino acids, glucose for the energy source, and serum for the source of growth, attachment factors & hormones.

The market report analysis is based on both primary and secondary data sources. Primary sources include interviews conducted with various industry analysts, suppliers and distributors, whereas secondary sources include data collected from government websites and annual report of companies and other relevant documents.

All the information provided in the study is corroborated by the global market leaders. The report underscores the use of top-down approach to evaluate figures for each market segment, which are then validated by leveraging the bottom-up approach.

Report Attribute Details
The market size value in 2021 USD 876.3 million
The revenue forecast in 2030 USD 1,524 million
Growth Rate CAGR of 8.5% from 2020 to 2028
The base year for estimation 2021
Historical data 2018 – 2020
Forecast period 2022 – 2030
Top Manufacturers Life Technologies, Avantor Performance Materials LLC, Sigma-Aldrich, Bio-Rad Laboratories Inc., Cell Essentials Inc., Atlanta Biologicals, Becton, Dickinson and Company, Caisson Laboratories Inc., Corning Incorporated, Cell Culture Technologies LLC, HiMedia Laboratories, Fujifilm Holdings, Lonza Group, Vitro Diagnostics Inc., Sartorius AG, Novozymes Biopharma US Inc., Merck & Co. Inc., Sera Scandia A/S, Thermo Fisher Scientific Inc., Takara Bio Inc., Cyagen Biosciences Inc., Analytical Biological Services Inc.
By Reagent Type

Albumin: Bovine Serum Albumin, Human Serum Albumin, Recombinant Human Serum Albumin, Hormones, Amino Acid, Attachment

Factors, Growth Factors & Cytokines: Tumor necrosis factors, Insulin-like growth factors, Interferons, Interleukins

By Type Chemically-defined Media, Specialty Media, Classical Media, Serum-free Media, Lysogeny Broth, Protein-free Media
By End-User
Biotechnology & Pharmaceutical Companies, Pathology Labs, Research Laboratories, Academic Institutes
By Application
Biopharmaceuticals & Therapeutics, Cancer, Stem Cell Technologies, Biotech Research, Drug Screening & Drug Development, Regenerative Medicine & Tissue Engineering
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Growth Factors

The culture media market is growing due to quick development in the sector of biopharmaceuticals, biotechnology, stem cell research, and oncology. In addition, the high requirement used for the culture media, and technological developments are the most important factors fuelling the market growth in the global cell culture media. Furthermore, innovation in the life science sector and growth in funding & investments in research and development is stimulating market growth.

Also, the culture media market share is anticipated to increase in the future, owing to accessibility and availability of customized and specialty media and the increase in adoption of the cell culture in the emerging markets.

However, the existence of potential and promising markets is likely to offer beneficial opportunities to the market industries in the global culture media market during the forecast period.

On the other hand, the ethical & scientific worry regarding culture media and the shortage of experienced professionals will hamper the growth of the cell culture media market.

Regional Analysis

The geographical split of the cell culture media market comprises North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. In terms of revenue, North America has the highest market share in the global cell culture media market due to the augment in developments regarding cell culture media, the increase in research and development investments, and higher requirements for cell culture media. This, in turn, is propelling the market growth in the region of North American.
The market-based in Asia-Pacific has the largest growth prospective due to multiple factors such as the growth in the healthcare sector & research expenses, the major economic progress and the availability of research amenities are driving the market of the cell culture media in the region during the forecast period.

Top Market Players

The several market players in the global cell culture media market include Life Technologies, Avantor Performance Materials LLC, Sigma-Aldrich, Bio-Rad Laboratories Inc., Cell Essentials Inc., Atlanta Biologicals, Becton, Dickinson and Company, Caisson Laboratories Inc., Corning Incorporated, Cell Culture Technologies LLC, HiMedia Laboratories, Fujifilm Holdings, Lonza Group, Vitro Diagnostics Inc., Sartorius AG, Novozymes Biopharma US Inc., Merck & Co. Inc., Sera Scandia A/S, Thermo Fisher Scientific Inc., Takara Bio Inc., Cyagen Biosciences Inc., Analytical Biological Services Inc., among others.

This report segments the global cell culture media market as follows:

Global Cell Culture Media Market: By Reagent Type

  • Albumin
    • Bovine Serum Albumin
    • Human Serum Albumin
    • Recombinant Human Serum Albumin
  • Hormones
  • Amino Acid
  • Attachment Factors
  • Growth Factors & Cytokines
    • Tumor necrosis factors
    • Insulin-like growth factors
    • Interferons
    • Interleukins

Global Cell Culture Media Market: By Type

  • Chemically-defined Media
  • Specialty Media
  • Classical Media
  • Serum-free Media
  • Lysogeny Broth
  • Protein-free Media

Global Cell Culture Media Market: By End-User

  • Biotechnology & Pharmaceutical Companies
  • Pathology Labs
  • Research Laboratories
  • Academic Institutes

Global Cell Culture Media Market: By Application

  • Biopharmaceuticals & Therapeutics
  • Cancer
  • Stem Cell Technologies
  • Biotech Research
  • Drug Screening & Drug Development
  • Regenerative Medicine & Tissue Engineering


Global Cell Culture Media Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

The Global Cancer Gene Therapy Market was valued at USD 558.24 million in 2019 and is estimated to reach USD 921.8 million by 2030, expanding at a CAGR of 32.6% during the forecast period, from 2020 to 2030.

Cancer gene therapy refers to the cancer treatment where therapeutic DNA is being introduced into the gene of the patient having cancer. The most commonly used technique for cancer gene therapy is replacing a mutated gene causing cancer with a healthy copy of the gene. Another technique used is the inactivation of a gene that is not functioning well. Lately, a new technique has been introduced to the cancer gene therapy market that is the insertion of new genes into the body which will help in fighting against the cancer cells. Due to its success rate in preclinical as well as clinical trial stages, cancer gene therapy is gaining recognition all over the world.

Key Growth Factors

The major factors such as the growing incidences of cancer population, favorable government initiatives, rising elderly population, and growing funds for research and development projects for cancer gene treatment are driving the growth of the global cancer gene therapy market. Other than this, ethical approval of cancer gene treatment and the rising recognition of DNA vaccines are propelling the global cancer gene therapy market over the forecast period. Furthermore, numerous cancer gene treatment products are in clinical trial phases. This, in turn, will continue to have a positive influence on the market. On the other hand, the available market in emergent countries, industrial developments leading to improved adoption, and ethical approval of cancer gene therapy treatment will create lucrative opportunities for the global market of cancer gene therapy market.

However, factors such as less awareness, high expenditure for cancer gene treatment, and unfavorable immune responses are likely to hamper the market growth of cancer gene therapy.

Regional Analysis

North America in terms of revenue is leading the global cancer gene therapy market, owing to the high geriatric population and industrial development in this region. Similarly, Europe is dominating the global market of cancer gene therapy. Moreover, the Asia-Pacific is likely to experience the highest growth in the cancer gene therapy market because of rising government programs, and growing cost-cutting measures and development in healthcare infrastructure. Also, other factors like the large population of patients, growing research and development investments, and increasing government funding in developing countries are responsible for market expansion.

Top Market Players

Some key market players in the global cancer gene therapy market include Vigene Biosciences, Cell Genesys, Sirion Biotech, Adaptimmune, Advantagene, Bluebird Bio, GenVec, Cobra, BioCancell, Cellectis, Sarepta Therapeutics, Epeius Biotechnologies, Uniqure, Introgen Therapeutics, ZIOPHARM Oncology, Finvector MultiVir, Shenzhen SiBiono GeneTech, GlaxoSmithKline, Merck, and Celgene.

Report Attribute Details
The market size value in 2019 USD 558.24 million
The revenue forecast in 2030 USD 921.8 million
Growth Rate CAGR of 32.6% from 2020 to 2030
The base year for estimation 2021
Historical data 2018 – 2020
Forecast period 2022 – 2030
Top Manufacturers Vigene Biosciences, Cell Genesys, Sirion Biotech, Adaptimmune, Advantagene, Bluebird Bio, GenVec, Cobra, BioCancell, Cellectis, Sarepta Therapeutics, Epeius Biotechnologies, Uniqure, Introgen Therapeutics, ZIOPHARM Oncology, Finvector MultiVir, Shenzhen SiBiono GeneTech, GlaxoSmithKline, Merck, and Celgene.
Product Types Ex-vivo, In-vivo
Application Types Viral Vectors, Non-viral Vectors, Others
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa

This report segments the global cancer gene therapy market as follows:

Global Cancer Gene Therapy Market: By Type

  • Ex-vivo
  • In-vivo

Global Cancer Gene Therapy Market: By Product

  • Viral Vectors
  • Non-viral Vectors
  • Others

Global Cancer Gene Therapy Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Total Reports : 4
Up